CRBP
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.46
−1.33%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$1.21
- Revenue estimate
- $2.0M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$1.81
- EPS estimate
- -$1.26
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -7.3%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $42
- PT range
- $35 – $48
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$1.26 | -$1.81 | Miss -43.65% | — |
| May 12, 2026 | -$1.26 | -$1.23 | Beat 2.38% | — |
| Mar 9, 2026 | -$1.52 | -$1.25 | Beat 17.64% | — |
| Nov 12, 2025 | -$1.80 | -$1.90 | Miss -5.56% | — |
| Mar 11, 2025 | -$1.02 | -$0.78 | Beat 23.53% | — |
| Nov 7, 2024 | -$0.99 | -$1.15 | Miss -16.16% | — |
| Mar 12, 2024 | -$2.36 | -$1.81 | Beat 23.31% | $1.3M |
| Mar 7, 2023 | -$2.10 | -$2.61 | Miss -24.29% | — |
| Mar 8, 2022 | -$3.30 | -$2.40 | Beat 27.27% | -$881.7K |
| Nov 12, 2021 | -$3.60 | -$0.60 | Beat 83.33% | $97.3K |
| Aug 12, 2021 | -$3.60 | -$4.50 | Miss -25.00% | $136.6K |
| May 13, 2021 | -$4.50 | -$4.20 | Beat 6.67% | $647.8K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026